Trial Profile
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Sep 2019
Price :
$35
*
At a glance
- Drugs Benzoyl peroxide/tretinoin (Primary)
- Indications Acne vulgaris
- Focus Therapeutic Use
- Sponsors Sol-Gel Technologies
- 26 Mar 2018 According to a Sol-Gel Technologies media release, data from this trial was presented at the American Academy of Dermatology (AAD) Annual Meeting 2018.
- 15 Feb 2018 According to a Sol-Gel Technologies media release, data will be presented at the 2018 American Academy of Dermatology (AAD) Annual Meeting
- 03 Oct 2017 Status changed from active, no longer recruiting to completed.